The global nucleic acid isolation and purification market has experienced significant growth due to the increasing demand for high-quality nucleic acid extraction methods in various sectors such as healthcare, biotechnology, pharmaceuticals, and research institutions. As molecular diagnostics, genomic research, and personalized medicine become more prevalent, the need for efficient, reliable, and scalable nucleic acid isolation and purification technologies has surged. The market is driven by advancements in technologies like Next Generation Sequencing (NGS), which require highly purified DNA and RNA for accurate analysis. Furthermore, the growing focus on genetic testing for personalized treatments and the expanding applications of nucleic acid isolation in areas like cancer research, forensic science, and infectious disease diagnostics are fueling market expansion. The market is characterized by a variety of solutions, including reagent kits, automated systems, and magnetic bead-based methods, which offer significant improvements in efficiency, accuracy, and speed compared to traditional manual techniques. Moreover, the rise in biotechnology and pharmaceutical research, particularly in emerging economies, has further boosted the adoption of these advanced techniques. Key players in the market are continually innovating to provide more cost-effective, user-friendly, and automation-driven solutions to meet the growing demands of scientific and clinical applications. With increasing investments in research and development and a shift towards molecular diagnostics, the market is expected to continue expanding in the coming years.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/global-nucleic-acid-isolation-purification-market
Global Nucleic Acid Isolation and Purification Market is expected to reach USD 15.44 billion by 2032 from USD 7.21 billion in 2024, growing with a CAGR of 10.6% in the forecast period of 2025 to 2032.
Key Findings of the Study
Rise in Technological Advancements and Automation
Advanced monitoring technologies have improved the accuracy and precision of monitoring systems. They provide with real-time, high-fidelity data on the patient's vital signs, including heart rate, blood pressure, and oxygen saturation. This precision allows for more individualized and targeted administration, reducing the risk of complications and ensuring optimal sedation levels. Modern monitoring systems often employ non-invasive techniques, reducing patient discomfort and the risk of infection.
Healthcare providers increasingly adopt the nucleic acid isolation and purification systems as these technological advancements evolve and provide more sophisticated and efficient solutions. These systems enhance patient safety during surgery and contribute to healthcare deliveries overall efficiency and quality. These innovations become more accessible and integral to modern healthcare practices, driving market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2025 to 2032
|
|
Base Year
|
2024
|
|
Historic Years
|
2018-2023 (Customizable to 2013-2017)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Thousand Units, Pricing in USD
|
|
Segments Covered
|
Product (Instruments, Kits, and Reagents), Method (Magnetic Bead-Based Isolation and Purification, Column -Based Isolation and Purification, Reagent-Based Isolation and Purification, and Others), Type (Next Generation Sequencing (NGS), Genomic DNA Isolation and Purification, Total RNA Isolation and Purification, PCR Clean-Up, Plasmid DNA Isolation and Purification, Messenger RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, MicroRNA Isolation and Purification, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, and Others), Sample Type (FFPE Samples, Blood Cells, Bacteria, Yeast, and Plants, Cell-Free Samples, Cultured Cells, Mammalian Cells, Brain and Kidney Tissue, and Others), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Contract Development and manufacturing Organization (CDMO), Academic/Research Institutes, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Russia, Turkey, Belgium, Netherlands, Denmark, Poland, Sweden, Norway, Finland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, New Zealand, Vietnam, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Qatar, Egypt, Kuwait, Bahrain, Oman, Rest of Middle East and Africa
|
|
Market Players Covered
|
Merck KGaA (Germany), Cutiva (Danaher Corporation) (U.S.), Meridian Bioscience, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Illumina Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Netherlands), Takara Bio Inc. (Japan), Promega Corporation (U.S.), MACHEREY-NAGEL GmbH & Co. KG (Germany), New England Biolabs (U.S.), Omega Bio-tek, Inc. (U.S.), Zymo Research Corporation (U.S.), Analytik Jena GmbH+Co. KG (Germany), MagGenome Technologies Pvt. Ltd. (India), AUTOGEN INC. (U.S.), Xi'an Tianlong Science and Technology Co., Ltd. (China), PCR Biosystems (UK), Sage Science, Inc. (U.S.), and ALS (Australia) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
Global nucleic acid isolation and purification market is categorized into six notable segments which are based on the product, method, type, application, sample type, and end user.
- On the basis of product, global nucleic acid isolation and purification market is segmented into instruments, kits, and reagents
In 2025, the instruments segment is expected to dominate the global nucleic acid isolation and purification market
In 2025, the instruments segment is expected to dominate the market with a market share of 47.19% due to increasing need for high-quality nucleic acid samples in research, diagnostics, and personalized medicine is driving the adoption of advanced instrumentation, further bolstering its market dominance.
- On the basis of method, global nucleic acid isolation and purification market is segmented into magnetic bead-based isolation and purification, column -based isolation and purification, reagent-based isolation and purification and others
In 2025, the magnetic bead-based isolation and purification segment is expected to dominate the global nucleic acid isolation and purification market
In 2025, the magnetic bead-based isolation and purification segment is expected to dominate the market with a market share of 46.70% due to advantages such as rapid processing, high purity, and minimal sample loss, making it ideal for high-throughput applications.
- On the basis of type, global nucleic acid isolation and purification market is segmented into Next Generation Sequencing (NGS), genomic DNA isolation and purification, total RNA isolation and purification, PCR clean-up, plasmid DNA isolation and purification, messenger RNA isolation and purification, circulating nucleic acid isolation and purification, MicroRNA isolation and purification and others. In 2025, Next Generation Sequencing (NGS) segment is expected to dominate the market with 30.84% market share
- On the basis of application, global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research and others. In 2025, diagnostics segment is expected to dominate the market with 41.82% market share
- On the basis of sample type, global nucleic acid isolation and purification market is segmented into FFPE samples, blood cells, bacteria, yeast, and plants, cell-free samples, cultured cells, mammalian cells, brain and kidney tissue, others. In 2025, FFPE samples segment is expected to dominate the market with 33.80% market share
- On the basis of end user, global nucleic acid isolation and purification market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, contract research organizations, Contract Development and manufacturing Organization (CDMO), academic/research institutes, others. In 2025, hospitals and diagnostic centers segment is expected to dominate the market with 35.44% market share
Major Players
Data Bridge Market Research analyses Merck KGaA (Germany), Cutiva (Danaher Corporation) (U.S.), Meridian Bioscience, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.) as the major market players operating in the market.
Market Developments
- In August 2024, Bio-Rad had launched the VeriCheck ddPCR Empty Full Capsid Kit, designed to enhance the development of safe and effective gene therapies. This high-precision kit enables accurate quantification of viral capsids, improving research and quality control in gene therapy applications
- In May 2024, Thermo, Fisher and BRIN have partnered to enhance research capabilities in Indonesia, focusing on advancing scientific innovation and collaboration in life sciences, biotechnology, and environmental studies for local researchers
- In September 2021, PerkinElmer, Inc. has successfully completed its acquisition of BioLegend for approximately USD 5.25 billion, marking its largest acquisition to date. This strategic move enhances PerkinElmer's life sciences portfolio in areas like cytometry and proteogenomics. Leaders from both companies anticipate collaborative innovation that will drive new therapeutic discoveries and advance scientific research
- In March 2025, Medtronic announced that it had been recognized by Ethisphere, a leader in defining and advancing the standards of ethical business practices, as one of the 2025 World's Most Ethical Companies opens a new window. This helped the organization develop a brand image among other leaders
- In April 2022, GE HealthCare. announced receiving the FDA Pre-Market Approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. This increased the company's product portfolio and overall revenue
Regional Analysis
Geographically, the countries covered in the global nucleic acid isolation and purification market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Russia, Turkey, Belgium, Netherlands, Denmark, Poland, Sweden, Norway, Finland, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, New Zealand, Vietnam, Taiwan, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Qatar, Egypt, Kuwait, Bahrain, Oman, rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America is the dominating region in the global nucleic acid isolation and purification market
North America holds the largest share of the market, attributed to its advanced healthcare infrastructure, substantial investment in research and development, and high innovation levels. Europe follows closely, with a strong market presence driven by similar factors.
Asia-Pacific is the fastest growing region in the global nucleic acid isolation and purification market
The Asia-Pacific region is expected to witness the fastest growth rate due to rapid advancements in healthcare infrastructure and increased investments in research and development across the region. Also, increasing prevalence of genetic disorders, increasing demand for diagnostic testing, rising investment in genomics research and increase in launch of diagnostic products are driving the adoption of global nucleic acid isolation and purification market.
For more detailed information about the global nucleic acid isolation and purification market report, click here – https://www.databridgemarketresearch.com/ar/reports/global-nucleic-acid-isolation-purification-market
